Report Date: 2022

In 2015, the World Health Organization (WHO) established the Global Antimicrobial Resistance and Use Surveillance System (GLASS) to monitor AMR in common bacteria and invasive fungi, and antimicrobial consumption (AMC) in humans. GLASS aims at collecting strategic information to inform the AMR response at the national and global levels. Since 2017, WHO has issued annual GLASS reports describing the expansion and gradual strengthening of the newly established global system. This edition of the GLASS report summarizes 2020 data from countries, territories, and areas (CTAs) on AMR rates and trends in common bacteria. For the first time, it also presents official data on the consumption of antimicrobial medicines at the national level. An innovative feature of the report is the contextualization of AMR findings based on an analysis of testing coverage, which varies substantially among CTAs contributing data from all regions of the world.